Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy.

Literature DB >> 21170003

Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy.

Paul A Gurbel, Udaya S Tantry.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2011 PMID： 21170003 DOI： 10.1038/nrcardio.2010.185

Source DB: PubMed Journal: Nat Rev Cardiol ISSN： 1759-5002 Impact factor: 32.419

× No keyword cloud information.

6 in total

1. Clopidogrel with or without omeprazole in coronary artery disease.

Authors: Deepak L Bhatt; Byron L Cryer; Charles F Contant; Marc Cohen; Angel Lanas; Thomas J Schnitzer; Thomas L Shook; Pablo Lapuerta; Mark A Goldsmith; Loren Laine; Benjamin M Scirica; Sabina A Murphy; Christopher P Cannon
Journal: N Engl J Med Date: 2010-10-06 Impact factor: 91.245

2. Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes.

Authors: Takahisa Furuta; Takayuki Iwaki; Kazuo Umemura
Journal: Br J Clin Pharmacol Date: 2010-09 Impact factor: 4.335

Review 3. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors: Neena S Abraham; Mark A Hlatky; Elliott M Antman; Deepak L Bhatt; David J Bjorkman; Craig B Clark; Curt D Furberg; David A Johnson; Charles J Kahi; Loren Laine; Kenneth W Mahaffey; Eamonn M Quigley; James Scheiman; Laurence S Sperling; Gordon F Tomaselli
Journal: Circulation Date: 2010-11-08 Impact factor: 29.690

4. Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.

Authors: Rolf P Kreutz; Eric J Stanek; Ronald Aubert; Jianying Yao; Jeffrey A Breall; Zeruesenay Desta; Todd C Skaar; J Russell Teagarden; Felix W Frueh; Robert S Epstein; David A Flockhart
Journal: Pharmacotherapy Date: 2010-08 Impact factor: 4.705

5. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.

Authors: Mette Charlot; Ole Ahlehoff; Mette Lykke Norgaard; Casper H Jørgensen; Rikke Sørensen; Steen Z Abildstrøm; Peter Riis Hansen; Jan Kyst Madsen; Lars Køber; Christian Torp-Pedersen; Gunnar Gislason
Journal: Ann Intern Med Date: 2010-09-21 Impact factor: 25.391

6. Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases.

Authors: Paul A Gurbel; Udaya S Tantry; Dean J Kereiakes
Journal: Drug Healthc Patient Saf Date: 2010-11-15

6 in total

5 in total

5. The decline effect in cardiovascular medicine: is the effect of cardiovascular medicine and stent on cardiovascular events decline over the years?

Authors: Moo-Sik Lee; Andreas J Flammer; Amir Lerman
Journal: Korean Circ J Date: 2013-07 Impact factor: 3.243

5 in total

Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy.

1. Clopidogrel with or without omeprazole in coronary artery disease.

2. Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes.

4. Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.

5. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.

6. Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases.

Review 1. The clinical relevance of the clopidogrel-proton pump inhibitor interaction.

2. Drug-drug interaction of rabeprazole and clopidogrel in healthy Chinese volunteers.

3. Proton pump inhibitor prescriptions and subsequent use in US veterans diagnosed with gastroesophageal reflux disease.

4. Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanisms.

5. The decline effect in cardiovascular medicine: is the effect of cardiovascular medicine and stent on cardiovascular events decline over the years?